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Abstract
FoxM1 is a forkhead box transcription factor and a known master regulator required for different phases of the cell cycle. In
cell lines, FoxM1 deficient cells exhibit delayed S phase entry, aneuploidy, polyploidy and can’t complete mitosis. In vivo,
FoxM1 is expressed mostly in proliferating cells but is surprisingly also found in non-proliferating CD4
+CD8
+ double positive
thymocytes. Here, we addressed the role of FoxM1 in T cell development by generating and analyzing two different lines of
T-cell specific FoxM1 deficient mice. As expected, FoxM1 is required for proliferation of early thymocytes and activated
mature T cells. Defective expression of many cell cycle proteins was detected, including cyclin A, cyclin B1, cdc2, cdk2, p27
and the Rb family members p107 and p130 but surprisingly not survivin. Unexpectedly, loss of FoxM1 only affects a few cell
cycle proteins in CD4
+CD8
+ thymocytes and has little effect on their sensitivity to apoptosis and the subsequent steps of T
cell differentiation. Thus, regulation of cell cycle genes by FoxM1 is stage- and context-dependent.
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Introduction
Proliferation and apoptosis are integral parts of T cell
development. Early thymocytes die if their T-cell receptor
(TCR) b genes do not rearrange successfully to produce a
functional protein. Formation of a cell surface pre-TCR complex,
consisting of TCRb/pTa/CD3 will result in proliferation and
differentiation of CD4
2CD8
2 (DN) thymocytes into CD4
+
CD8
+(DP) thymocytes [1–5]. DP cells are exquisitely sensitive to
apoptosis and live only for 3–5 days in vivo. Only a small fraction of
DP cells with the appropriate TCRab/CD3 complex can
differentiate into CD4
+CD8
2 or CD4
2CD8
+ SP thymocytes.
These cells migrate to the peripheral immune organs, spleen and
lymph nodes. Early in life, when these organs are relatively empty,
homeostatic proliferation of SP cells takes place to fill the empty
niches. This homeostatic proliferation ceases in adult mice.
Mature T cells exist in the G0 state of the cell cycle and proliferate
only when stimulated through their TCR complex.
Regardless of their cell types, cell cycle progression in
mammalian cells is tightly regulated by the rise and fall of the
cyclin/CDK kinase activities. Entry into the S phase requires
activation of the CDK4/cyclin D or CDK6/cyclin D and the
CDK2/cyclin E activities [6,7]. The latter kinase phosphorylates
the Rb family members Rb, p107 and p130, which then release
the E2F transcription factors required for cell entry into the S
phase [8,9]. In S phase, CDK2/cyclin A is active while cyclin B/
CDK1 is crucial for the G2/M phases of the cell cycle. FoxM1
belongs to the forkhead family of transcription factors that include
Foxp3, Foxo3 and other Fox family proteins crucial for a wide
variety of biological processes [10–15]. FoxM1 is known to be a
master regulator of cell cycle proteins that are expressed in
proliferating cells. Its known direct target genes include cyclin D1,
c-myc, cyclin B1, p27, p21, G2/M specific protein survivin and
many other cell cycle related proteins. In cell lines and some
primary cells, FoxM1 deficient cells fail to proliferate and exhibit
aneuploidy and polyploidy [15,16] with many similarities to that of
survivin deficient cells [17,18]. In adult mice, FoxM1 is highly
expressed in the testis, small intestine, colon and thymus [19,20].
Thymus contains different T-cell populations but only a small
fraction is proliferating (DN thymocytes). FoxM1 presumably is
expressed in proliferating DN thymocytes but it is also found in DP
cells, which constitute .85% thymocytes. However, DP thymo-
cytes exist in 2N DNA content and do not proliferate [21]. In
addition to FoxM1, DP thymocytes express many cell cycle
proteins, including survivin, cyclin A, cyclin B1, cyclin D, CDK2,
cdc2, p27, p21 and the RB family members p107, p130.
Differentiation of DP thymocytes into SP cells results in down-
regulation of FoxM1 as well as other cell cycle proteins [21,22].
We hypothesized that expression of these cell cycle genes in DP
thymocytes might contribute to their inherent sensitivity to
apoptosis. As FoxM1 is a master cell cycle gene for many cell
cycle proteins, we deleted FoxM1 from DP thymocytes by crossing
floxed FoxM1 mice [23] to two different T cell specific Cre
transgenic mice (lck-Cre and CD4-Cre) [24,25]. Analysis of lck-Cre/
FoxM1
fl/fl mice showed that deletion of FoxM1 starting from DN
thymocytes results in a 2-fold drop of the DP thymocyte
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9229population followed by a similar drop of mature peripheral T cells.
In contrast, T cell development appears to be normal in CD4-Cre/
FoxM1
fl/fl mice although mature T cells exhibit defective
proliferation when stimulated. Interestingly, expression of a few
cell cycle proteins is affected in FoxM1-deficient DP thymocytes.
Apoptosis of FoxM1-deficient DP cells appears to be normal. We
concluded that FoxM1 is an important factor for mature T cells
and early T cell subsets but not for DP thymocytes.
Results
Abnormal T Cell Development of lck-Cre/FoxM1
fl/fl Mice
We crossed floxed FoxM1 mice [23,26] to lck-Cre mice to
generate lck-Cre/FoxM1
fl/fl mice (henceforth termed lck-FoxM1).
In these mice, Cre is expressed early during development starting
in the DN2 T cell population (CD4
2CD8
2 CD25
+ CD44
+) [18].
Deletion of FoxM1 is thus expected to occur before the pre-
TCR mediated proliferation that takes place between DN3
(CD4
2CD8
2 CD25
2CD44
+) and DN4 (CD4
2CD8
2 CD25
2
CD44
2) T cells. In a similar knockout mouse strain of survivin
gene (lck-Cre/survivin
fl/fl), for example, loss of survivin at this stage
leads to a severe block in the DN to DP transition and more than
10-fold drop of the number of thymocytes [17,18]. Unexpectedly,
however, lck-FoxM1 mice only exhibit a two-fold reduction in the
number of total thymocytes (Fig. 1A). The number of DN
thymocytes remains similar and reduction starts in intermediated
single positive (TCR
low CD8
+CD4
2) thymocytes (1.5 fold) followed
by a 2-fold drop of DP thymocytes (Fig. 1A, 1B and data not
shown). Positive selection (differentiation into CD4 or CD8 SP
thymocytes) doesn’t seem to be affected as the expression profiles of
markers for positive selection, CD69 and HSA, are normal (data not
shown). The CD25/CD44 staining profiles of DN thymocytes
confirmed that loss of FoxM1 leads to accumulation of the DN3
thymocytes (Fig. 1B). Loss of FoxM1 in DP thymocytes and later T
cell stages was confirmed using western blot analysis (see below).
Analysis of the peripheral immune organs, spleen and lymph nodes
also showed a similar modest drop of CD4 and CD8 mature T cells
(Fig. 1C). We concluded that the absence of FoxM1 early during T
cell development only modestly affects the transition of DN to DP T
cells and has no effect in later stages of T cell differentiation.
CD4-Cre/FoxM1
fl/fl Mice Exhibit Normal T Cell
Development but Defective Proliferation of Mature T
Cells
To bypass the requirement of FoxM1 in the proliferative stage
of early T cell development, we bred the floxed FoxM1 mice to the
CD4-Cre transgenic mice [25] to generate CD4-Cre/FoxM1
fl/fl mice
(henceforth termed CD4-FoxM1). The Cre recombinase in CD4-
Cre mice is not expressed until late stage of DN thymocytes [18]
and thus FoxM1 should not be deleted until DP stage. In CD4-Cre
survivin deficient mice, T cell development is normal in adult mice
although the number of mature T cells drops due to defective
homeostatic proliferation that takes place in the neonatal stage
[18]. In CD4-FoxM1 mice, thymocyte cellularities and flow
cytometric profiles are completely normal (Fig. 2), including the
CD25/CD44 profile of their DN thymocytes. There is no
difference of the percentages and total numbers of CD4/CD8
mature T cells in spleen and lymph nodes between CD4-FoxM1
mice and their wild-type controls (Fig. 2C). This later datum
suggests that the neonatal homeostatic proliferation of mature T
cells is normal in CD4-FoxM1 mice.
To see if FoxM1 is required for proliferation of mature T cells,
we purified peripheral T cells from CD4-FoxM1 mice and
subjected them to cross-linking by anti-CD3/CD28 antibodies.
To measure the ability of these cells to enter the G1 cell cycle
phase, we used Ki-67, a nuclear marker whose expression
correlates with proliferation [27] and BrdU incorporation. As
shown in figure 3A, while wild-type CD4 and CD8 T cells
incorporated BrdU and expressed Ki-67, FoxM1-deficient T cells
exhibited a dramatic reduction of both Ki-67 levels and BrdU
incorporation. Propidium iodide staining further confirmed the
reduction of cells in the S and G2/M phases of the cell cycle in
FoxM1-deficient T cells (Fig. 3B) but no obvious block at the S to
G2/M transition was seen. Interestingly, polyploidy cells were not
observed. Thus, FoxM1 is a critical molecule for mature T cell
during the early G1 to S transition.
Loss of FoxM1 Leads to Loss of Cyclin B1 but Not Survivin
in DP Thymocytes
As a master regulator of cell cycle genes, loss of FoxM1 was
expected to lead to a wide spread dys-regulation of cell cycle
proteins. To see if this is the case, we isolated cell extracts from
sorted DP thymocytes, purified naı ¨ve T cells and activated mature T
cells. Western blot analysis was then carried out using antibodies
specific for each individual cell cycle protein. As we reported
previously, DP thymocytes express many cell cycle proteins [21].
Expression of these proteins is extinguished following positive
selection but is re-activated when mature T cells are stimulated to
undergo proliferation. In DP cells of lck-FoxM1 mice, only residual
FoxM1 protein was detected (Fig. 4A). In contrast, the level of
FoxM1 was reduced but not eliminated in DP cells of CD4-FoxM1
mice (Fig. 4B), presumably due to the long half-life of the FoxM1
protein. Activated T cells from both lines of mice had undetectable
levels of FoxM1. The difference in FoxM1 protein levels between
these two strains of mice is likely due to the differential kinetics of
FoxM1 deletion during T cell development. Consistent with the
earlier reports [18,25], semi-quantitative PCR analysis of the deleted
and wild-type FoxM1 alleles from lck- and CD4-FoxM1 mice
showed higher levels of FoxM1 deletion in DN3 and DN4
thymocyte populations of lck-FoxM1 mice (Fig. 4D). Surprisingly,
survivin levels were largely unchanged in DP cells and activated T
cells of both lck-FoxM1 and CD4-FoxM1 mice (Fig. 4A, B). This is
different to what others have found in FoxM1 knockdown cell lines
[28]. A small reduction of survivin level could be consistently seen in
naı ¨ve mature T cells of CD4-FoxM1 mice. However, since FoxM1
is normally not expressed in naı ¨ve T cells, this reduction is most
likely due to an indirect effect of FoxM1 deficiency. As expected,
cyclin B1 level was severely impacted by loss of FoxM1 in DP and
activated T cells of lck-FoxM1 mice. It was reduced in DP and
activated T cells from CD4-FoxM1 mice. No other cell cycle
proteins examined so far were affected in DP thymocytes of lck-
FoxM1 or CD4-FoxM1 mice. These include the Rb family
members p107 and p130, cdc2, cdk2, cyclin A and the cell cycle
inhibitor p27 (Fig. 4A, B). Quantitative RT-PCR of p107, CDK2,
cyclin E and p130 showed that transcripts of these genes didn’t go
down in FoxM1-deficient DP cells from lck-FoxM1 mice (Fig. 4C
and data not shown). In contrast to thymocytes, TCR stimulated
FoxM1-deficient mature T cells had lower or very little expression of
p107, cdc2, cyclin A and cdk2 compared to their wild-type controls.
FoxM1-deficient naive T cells also expressed lower levels of p27 and
p130 (Fig. 4A). We concluded that FoxM1 is a master regulator of
cell cycle proteins in mature T cells but not in DP thymocytes.
Normal Levels of Apoptosis in FoxM1 Deficient DP
Thymocytes
The cell cycle status might affect the sensitivity to apoptosis
[29]. Expression of the cell cycle proteins in DP cells might thus
The Role of FoxM1 in T Cells
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FoxM1 might affect apoptosis of DP cells, we measured apoptosis
of lck-FoxM1 DP thymocytes when cultured in vitro and when
stimulated with different apoptotic-inducing signals. Cultured
FoxM1-deficient DP thymocytes were slightly more sensitive to
apoptosis and cell death (Fig. 5). However, no changes in
differential apoptosis were observed when apoptotic stimuli (anti-
CD3/CD28, anti-Fas antibodies, phorbol ester PMA or dexa-
methasone) were added. It is not clear how loss of FoxM1
contributes to increased sensitivity of cell death in DP cells.
Figure 1. Characterization of lck-FoxM1 mice. (A) The total number of thymocytes, double negative (DN) cells, and double positive (DP) cells
from each mouse are depicted as a box or a circle (n=9). The average number of the total thymocytes (X 10
6) are 4126117 for wild-type mice and
193695 for the lck-FoxM1 mice (p,0.05). The average number (X 10
6) for DN thymocytes are 29.169.7 for wild-type mice and 31.2619.9 for lck-
FoxM1 mice. For DP thymocytes, the average number (X 10
6) is 3156119 for wild-type mice and 134686 for lck-FoxM1 mice (p,0.05). (B)
Representative plots of CD4 versus CD8 profiles of total thymocytes and CD44 versus CD25 profiles of gated DN thymocytes are shown. (C) CD4 versus
CD8 profiles and the total number of cells in lymph nodes are shown here. Right panel: Each box or circle represents one mouse (n=9). The average
number of the total lymph nodes cells (X 10
6) are 125637 for wild-type mice and 66.9618.9 for the lck-FoxM1 mice (p,0.05).
doi:10.1371/journal.pone.0009229.g001
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inhibitors of FoxM1, can induce cell death in transformed cells
[30,31].
Discussion
FoxM1, a member of the forkhead box family of transcription
factors, is a known master regulator of cell cycle-specific genes. In
cell lines and several primary tissues, FoxM1 was shown to directly
regulate many cell cycle-specific genes, including the G1/S specific
genes (cyclin D1, Skp2 and Cks1), the S phase-specific gene c-myc,
the G2/M genes (cdc25B and cyclin B1) and those that are
involved in mitosis (aurora, survivin and CENP) [15]. During T
cell development, FoxM1 is expressed at a high level in DP
thymocytes and proliferating DN thymocytes [19,20]. The
expression level of FoxM1 is down-regulated as DP cells
Figure 2. Characterization of CD4-FoxM1 mice. (A) The total number of thymocytes, double negative (DN), and double positive (DP) from each
mouse are depicted as a box or a circle (n=8). (B) Representative plots of CD4 versus CD8 profiles of total thymocytes and CD44 versus CD25 profiles
of gated DN thymocytes are shown. (C) CD4 versus CD8 profiles and the total number of cells in lymph nodes are shown here. Right panel: Each box
or circle represents one mouse (n=8).
doi:10.1371/journal.pone.0009229.g002
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in naı ¨ve T cells but is re-expressed when mature T cells are
activated to proliferate through their TCR. We are interested in
understanding why DP thymocytes are not proliferating but they
express many cell cycle proteins, including FoxM1 [21,22]. DP
thymocytes are exquisitely sensitive to apoptosis. We hypothesize
that the sensitivity to apoptosis is due to the widespread expression
of cell cycle proteins. We’d thus like to see if loss of FoxM1 might
lead to global down-regulation of cell cycle activities in DP
thymocytes and resistance to apoptosis.
We have generated and analyzed two lines of T-cell specific
FoxM1 deficient mice. In lck-FoxM1 mice, the FoxM1 exons
(exon 4–7) were deleted at the early DN stage and this occured at a
higher efficiency than CD4-FoxM1 mice. Reduction of FoxM1
protein is fairly complete by the time thymocytes differentiate into
CD4
+CD8
+ DP cells. Loss of FoxM1 at the early stage in lck-
Figure 3. Reduced expression of FoxM1 affects proliferation of peripheral T cells. For both (A) and (B), purified peripheral T cells from CD4-
FoxM1 mice or their wild-type littermate controls were stimulated with plate-bound anti-CD3/CD28 antibodies for 48 hr. (A) Left panel: non-G0 cells
were measured by Ki-67 staining. The percentages of Ki67
+ cells are as shown as the numbers in the figure. Right panel: Proliferation was measured
using BrdU incorporation. The percentages of BrdU
+ cells are as shown numbers in the figure. (B) Propidium iodide (PI) staining. The percentages of
cells in both S and G2 phases were shown in the figure. The cell cycle analysis was done for the samples stimulated for 48 hr: wild-type (G1=34.9%,
S=57.8%, and G2/M=5.9%) and CD4-FoxM1 (G1=56.3%, S=33%, and G2/M=5.82%). These experiments were repeated several times with similar
results.
doi:10.1371/journal.pone.0009229.g003
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CD28 stimulated T cells (activated T) of (A) lck lck-FoxM1 or (B) CD4-FoxM1 were analyzed by western blot analysis using antibodies specific for
FoxM1, survivin, cyclin B1, p107, cdc2, p27
kip1, cyclin A, cdk2, p130 and anti-actin for loading control. Western blot analysis of lck-FoxM1 cells using
antibodies specific for p27, cyclin A, cdk2 and p130 was also carried out. (C) Quantitative real-time PCR of cdk2 and p107 using sorted DP thymocytes
of lck-FoxM1 mice and their wild-type littermate controls. These experiments were repeated several times with similar results. (D) Semi-quantitative
PCRs of the FoxM1 deleted and wild-type alleles using primers as described in [36].
doi:10.1371/journal.pone.0009229.g004
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drop of the DP thymocytes followed by a similar reduction of SP
thymocytes and mature T cells. This modest phenotype is different
from that of lck-Cre/survivin
fl/fl mice, which suffer from an almost
complete block of DN to DP development [18]. Residual survivin
protein could also be seen in DP thymocytes of lck-Cre/survivin
fl/fl
mice. The difference in the requirement of survivin versus FoxM1
in early T cell development could be due to an unknown regulator
that compensates for the loss of FoxM1 in early T cells.
Alternatively, FoxM1 protein might be more stable than survivin
and thus there is just enough protein for DN to undergo
proliferation despite deletion of their FoxM1 alleles.
Surprisingly, loss of FoxM1 has no effect on most of the cell
cycle proteins expressed in DP thymocytes. DP thymocytes are an
unusual group of cells. They do not proliferate but yet they express
all the cell cycle proteins examined to date [21,32]. These include
FoxM1, survivin, cyclin B1, cyclin A, cdc2, cdk2, cyclin E, p21,
p27 and the Rb family members Rb, p107 and p130. Intracellular
staining studies with antibodies against a few of these proteins
showed that their expression is not restricted to a subgroup of DP
cells but in all DP cells [21]. As DP cells mature into SP
thymocytes, expression of these proteins is extinguished. Down-
regulation can also be seen at the transcription levels [22]. Given
the role of FoxM1 as a master cell cycle regulator in other cell
types [23,28,33], including mature T cells (this report), it is
surprising to see that cyclin B1 is the only protein whose expression
is being affected in FoxM1-deficient DP thymocytes. No changes
were found for p107, cdc2, p21, cyclin A, cdk2, p130, p27 or
survivin levels. As cyclin B1 is affected, it is unlikely that the
residual FoxM1 protein can be responsible for the normal
expression levels of these other cell cycle genes. One possibility
is the presence of yet another master regulator that compensates
for the loss of FoxM1.
The lack of effect of FoxM1 deficiency on survivin levels is
surprising. Survivin has been shown to be a direct target of FoxM1
in cell lines and in primary colon cells [28,30,34]. Even in
activated mature T cells where many of the cell cycle proteins are
being affected by FoxM1, survivin protein could be detected at a
significant level. It is possible that transcriptional regulation of
survivin by FoxM1 is cell type dependent. Further research will be
necessary to identify the upstream regulator of survivin in T cells
and to understand the molecular mechanisms that regulate cell
cycle levels in DP thymocytes.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the campus
Animal Care and Use Committee.
FoxM1 Knockout Mice
T-cell conditional FoxM1 knockout mice were generated by
crossing FoxM1
flox/flox mice to Lck-Cre or CD4-Cre transgenic mice,
which express Cre recombinase at different DN stages. For
genotyping Cre/FoxM1
flox/flox mice, two pairs of primers were used
for PCR: Cre 59 (CCAGCTAAACATGCTTCATCGTC) and
Cre 39 (CCTGATCCTGGCAATTTCGG); FoxM1 59 (TAG-
GAGATACACTGTTATAT) and FoxM1 39 (TGTGGGAAA-
ATGCTTACAAAAG).
Flow Cytometric Analysis
Cells were prepared from lymphoid organs of littermates. After
red blood cell lysis, they were stained with the indicated
antibodies. Anti-CD4, anti-CD8, anti-TCRb, anti-CD44, and
Figure 5. Lack of FoxM1 expression increased apoptosis of DP thymocytes in culture. Left panel: apoptosis of DP thymocytes (Annexin V
+
7ADD
2) culture in vitro for 24 hr. Middle panel: total number of cell death as measured by Annexin V
+ 7ADD
+ of DP thymocytes culture in vitro for
24 hr. Right panel: DP thymocytes from Lck-FoxM1 mice or their wild-type littermate controls were stimulated with anti-CD3/CD28, anti-Fas antibody,
PMA phorbol ester (PMA) or dexamethasone (Dex). The extent of apoptosis (% Annexin V positive, 7-AAD negative cells) was measured 24 hours
later.
doi:10.1371/journal.pone.0009229.g005
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Intracellular staining was performed as described previously [35].
Briefly, formaldehyde was added directly to culture medium to a
final concentration of 2% and incubated for 10 min at room
temperature. The cells were pelleted, resuspended in ice-cold
methanol, and incubated for 15–30 minutes on ice. The cells were
then washed three times with staining buffer (0.5% BSA in PBS)
and stained with antibodies of interest. Fresh isolated thymocytes
and peripheral T cells were fixed and stained with anti-Ki-67
antibody. Column-purified peripheral T cells were stimulated with
plate-bound anti-CD3 (2 mg/mL) and anti-CD28 (2 mg/mL) for
48 hours, fixed and then stained with anti-Ki-67 antibody. Anti-
Ki-67 antibody was purchased from BD Bioscience. BrdU
incorporation was performed as following: column-purified
peripheral T cells were stimulated with plate-bound anti-CD3
(2 mg/mL) and anti-CD28 (2 mg/mL) for 24 hours and 10 mMo f
BrdU was added into cell culture medium for another 16 hours.
The BrdU staining was measured after cells were fixed. The anti-
BrdU antibody was purchased from Caltag. PI staining was
performed by re-suspending cells in PBS containing 200 mg/ml
RNase, 50 mg/ml propidium iodide, 0.1% sodium citrate, and
0.1% (v/v) Triton X-100.
Western Blotting
Cell lysates were prepared from sorted DP thymocytes,
CD4
+CD8
2 SP thymocytes, CD4
+ peripheral T cells or CD8
+
peripheral T cells. The following antibodies used in this study:
anti-FoxM1, anti-cdc2, anti-cdk2, anti-cyclin A, anti-p130, anti-
p27, anti-p107, anti-survivin and anti-cyclin B1 antibodies were
purchased from Santa Cruz Biotechnology; and anti-actin
antibody was purchased from Abcam.
Apoptosis Assay
Thymocytes was isolated and stimulated with plate-bound anti-
CD3 (2 mg/mL) and anti-CD28 (2 mg/mL), anti-Fas (2 mg/mL),
PMA (0.6, 1.2 ng/mL) or Dexamethasone (4.5, 9.0 nM). After the
indicated time, cells were collected and stained with cell surface
markers, CD4 and CD8, as well as Annexin V (BD Biosciences)
and 7-AAD for flow cytometric analysis.
Quantitative Real-Time RT-PCR
Total RNAs were extracted from sorted DP thymocytes. The
primer sequences used in RT-PCR are: CDK2 forward (59-
GCACGATCCATACCCTCTGT) and reverse (59-CCCATTT-
TGGTCTGCTCAAT), p107 forward (59-GGAGATTGGAA-
CACCTCGAA) and reverse (59-ATACCGCCGTCCAGTAA-
GTG), as well as GAPDH forward (59-ACCCAGAAGACTGTG-
GATGG) and reverse (59-GGATGCAGGGATGATGTTCT).
Semi-quantitative PCR. Genomic DNAs were extracted from
sorted DN3, DN4, ISP (intermediate single positive) and DP
thymocytes of wild-type, CD4-FoxM1 or lck-FoxM1 mice. The
primer sequences used in PCR for the FoxM1 deleted allele are
forward (59-TGGCTTCCCAGCAGTACAAATC) and reverse
(59- TCTCGCTCAATTCCAAGACCAG); the primers for the
FoxM1 wild-type allele are forward (59-TGGCTTCCCAGCAG-
TACAAATC) and reverse (59-TGCTTACAAAAGACACACT-
TGGACG); and GAPDH forward (59-TGGCAAAGTGGA-
GATTGTTGCC) and reverse (59-AAGATGGTGATGGG-
CTTCCCG). The amounts of genomic DNA used for semi-
quantitative PCR were 2 mg/L, 0.4 mg/L, and 0.08 mg/L.
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